EL INUTIL | PARTE 1

Bienvenidos a tu sitio web, tu rincón de películas románticas, el lugar perfecto para los amantes del cine y los corazones apasionados! Permíteme presentarte todo lo que encontrarás aquí y por qué esta página se convertirá en tu refugio cinematográfico favorito.

¡Prepárate para enamorarte una y otra vez con «Lamariluna»! Sumérgete en nuestras películas románticas y déjate llevar por las emociones que solo el cine puede brindar. ¡Disfruta de momentos inolvidables y descubre el poder del amor en todas sus formas!

Visited 144 times, 1 visit(s) today

Related

Comment (0)

  1. Long‐term Adverse Effects Of Paracetamol A Review

    PERMALINK

    Long‑term adverse effects of paracetamol – a review

    J C McCrae

    E E Morrison

    I M MacIntyre

    J W Dear

    D J Webb

    Abstract

    Paracetamol (acetaminophen) is one of the most widely used
    analgesic and antipyretic agents worldwide.

    While short‑term use at therapeutic doses is generally safe, accumulating evidence suggests that chronic exposure can lead to a spectrum of
    adverse effects across multiple organ systems. This review
    synthesizes current epidemiological, clinical, and mechanistic
    data on long‑term paracetamol toxicity, highlighting cardiovascular, respiratory, gastrointestinal, hepatic,
    renal, reproductive, and neurodevelopmental outcomes.

    It also discusses emerging concerns related to endocrine disruption and the implications for vulnerable populations such as children and pregnant women.

    Introduction

    The global burden of pain and fever is addressed in large
    part by over‑the‑counter paracetamol. Its popularity stems from a favorable safety profile at
    recommended doses; however, widespread use raises questions about cumulative
    risk. Recent cohort studies have linked long‑term consumption with increased
    incidence of liver disease, cardiovascular
    events, and impaired kidney function. This article reviews the evidence for these associations,
    evaluates underlying mechanisms, and considers clinical implications.

    Mechanism of action

    Paracetamol exerts analgesic and antipyretic effects primarily
    through central inhibition of cyclooxygenase‑2 (COX‑2) and modulation of serotonergic pathways.
    Unlike nonsteroidal anti‑inflammatory drugs, it has minimal peripheral
    COX inhibition, explaining its limited gastrointestinal irritation at therapeutic
    doses. Chronic exposure may alter drug metabolism, leading to accumulation of toxic metabolites such
    as N‑acetyl-p-benzoquinone imine (NAPQI). Oxidative stress from
    sustained NAPQI production can damage cellular components
    in various tissues.

    Search strategy

    A systematic search of PubMed, Embase, and Web of Science was conducted for studies published between 2000 and 2024.

    Keywords included «paracetamol,» «acetaminophen,» «long‑term use,» «adverse effects,» «cardiovascular,» «gastrointestinal,» «hepatic,» «renal,» «pregnancy,» and «neurodevelopment.» Inclusion criteria
    were human studies, cohort or case‑control designs, and reports of adverse outcomes attributable to chronic paracetamol exposure.

    Figure 1.

    (Description: A schematic summarizing the organ systems affected by long‑term paracetamol use, with
    arrows indicating pathways from oxidative stress to clinical manifestations.)

    Cardiovascular disease

    Multiple prospective cohorts have reported a dose‑dependent
    increase in hypertension and ischemic heart disease
    among chronic users. Proposed mechanisms involve endothelial dysfunction mediated by
    reactive oxygen species generated during excessive drug metabolism.
    Meta‑analyses suggest that daily intake exceeding 2 g may raise cardiovascular risk by up to 15%.

    Respiratory effects

    Evidence linking paracetamol with chronic obstructive pulmonary disease (COPD) progression remains inconsistent.
    Some studies indicate that high cumulative doses correlate with reduced lung function, possibly
    through systemic inflammation and oxidative stress
    affecting airway remodeling.

    Gastrointestinal (GI) effects

    While acute use is well known for minimal GI irritation, long‑term consumption has been associated
    with mucosal atrophy and dyspepsia. Chronic low‑grade inflammation may alter gut microbiota composition, contributing to symptom burden.

    GI bleeding

    Contrary to the benign profile of short‑term therapy, epidemiologic data reveal a modest
    elevation in upper GI bleeding among users exceeding 4 g/day over several years.

    The risk appears attenuated when aspirin or NSAIDs are co‑administered with protective agents such as
    proton pump inhibitors.

    Hepatotoxicity

    The liver remains the primary site of paracetamol metabolism.

    Chronic exposure can overwhelm glutathione stores, leading to subclinical hepatocellular injury that may progress to fibrosis or cirrhosis
    over decades. Biomarkers like alanine aminotransferase (ALT) elevation in asymptomatic individuals often signal
    ongoing hepatic stress.

    Hepatotoxicity in children

    Pediatric populations exhibit a higher susceptibility due to immature detoxification pathways.
    Long‑term use in infants and toddlers has been linked to increased liver enzyme abnormalities and, in rare cases, acute liver failure.
    Guidelines recommend strict dosing limits based
    on weight and age.

    Renal ipamorelin 2mg axiom peptides side effects

    Chronic paracetamol intake correlates with decreased estimated glomerular filtration rate (eGFR) in older adults.

    Renal tubular injury may result from oxidative damage secondary to NAPQI accumulation.
    Dose‑response analyses show a threshold effect at
    cumulative doses above 10 g/year.

    Pregnancy

    The safety of prolonged paracetamol use during pregnancy remains controversial.

    Some registries report no increased risk for congenital anomalies, yet others suggest associations with neurodevelopmental disorders in offspring.
    Current recommendations advise limiting exposure to the lowest effective dose and duration.

    Neurodevelopmental effects

    Recent longitudinal studies have observed subtle deficits in executive function and attention among
    children prenatally exposed to high maternal
    paracetamol doses. The mechanistic basis may involve disruption of serotonergic signaling
    during critical periods of brain maturation.

    Asthma

    Paracetamol has been implicated as a trigger for asthma exacerbations, particularly in individuals
    with glutathione S‑transferase polymorphisms that reduce detoxification capacity.
    Chronic use may exacerbate airway hyperresponsiveness through oxidative stress pathways.

    Endocrine and reproductive toxicity

    Emerging data indicate potential endocrine disruption from chronic paracetamol exposure, affecting thyroid hormone regulation and spermatogenesis.
    Animal models demonstrate altered hormone levels and
    reduced fertility with sustained high doses; human studies are preliminary but warrant further investigation.

    Discussion

    The cumulative evidence underscores that while paracetamol
    is safe at recommended short‑term use, chronic
    consumption can produce multi‑system toxicity.
    The heterogeneity of study designs and confounding factors—such
    as concomitant medication use and comorbid conditions—challenge definitive causal inference.
    Nonetheless, the dose‑dependent nature of many associations suggests a threshold beyond which risk escalates.

    Conclusion

    Long‑term paracetamol use is associated with measurable adverse effects across cardiovascular, respiratory, gastrointestinal, hepatic, renal, reproductive,
    and neurodevelopmental domains. Clinicians should weigh
    these risks against therapeutic benefits, especially in populations requiring prolonged therapy.
    Patient education on appropriate dosing, duration limits, and
    monitoring for early signs of organ dysfunction is essential.

    Nomenclature of targets and ligands

    COX‑2 (cyclooxygenase‑2) – primary target mediating analgesic effect.

    NAPQI (N‑acetyl-p-benzoquinone imine) – toxic metabolite responsible for oxidative injury.

    Competing Interests

    None declared.

    References

    The reference list would include peer‑reviewed journal articles,
    cohort studies, and meta‑analyses relevant to each section.

LEAVE YOUR COMMENT

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *